Clinical value and limitations of serum CA19-9 as a biomarker of pancreatic cancer
Timely diagnosis and effective treatment of pancreatic cancer remains a distinct clinical challenge. Serum carbohydrate antigen (CA19-9) has emerged as a promising biomarker of pancreatic tumors and clinical studies have indicated its potential benefit in diagnosis, prognosis, and management of the...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2013-03-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Subjects: | |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=5280&ClassID=21135522 |